Liposomal NMN yog biologic uas ua ke liposome technology nrog NMN (niacin mononucleotide). NMN yog ib yam khoom uas muaj peev xwm tiv thaiv kev laus thiab ntseeg tau tias yuav txhim kho cellular zog metabolism, txhim kho cell vitality thiab tiv thaiv hlwb los ntawm oxidative kev nyuaj siab. Liposomes yog cov khoom uas tsim los ntawm ob txheej lipid qauv zoo ib yam li cov cell membrane, uas tuaj yeem pab yaj thiab nqus cov tshuaj, yog li txhim kho lawv cov bioavailability. Encapsulating NMN hauv liposomes txhim kho kev ruaj ntseg thiab bioavailability ntawm NMN thiab ua rau nws yooj yim dua los ntawm cov hlwb. Liposome NMN ntseeg tau tias muaj cov txiaj ntsig zoo hauv qab no: Txhim kho kev nqus tau zoo: Los ntawm encapsulating nws hauv liposomes, solubility thiab stability ntawm NMN tuaj yeem txhim kho, yog li ua kom muaj kev nqus tau zoo rau hauv cov hlwb. Ntxiv bioavailability: Liposomes tuaj yeem pab NMN hla cell membranes zoo dua, txhim kho nws cov bioavailability thiab cia nws ua haujlwm zoo dua. Muab kev tiv thaiv: Liposomes tuaj yeem tiv thaiv NMN los ntawm kev puas tsuaj los ntawm acidic gastric kua txiv thiab lwm yam digestive enzymes, yog li ua kom nws ruaj khov thiab bioavailability nyob rau hauv txoj hnyuv. Feem ntau, liposomal NMN yog cov tshuaj lom neeg uas ua ke nrog liposome technology thiab NMN. Los ntawm kev txhim kho kev ruaj ntseg thiab bioavailability ntawm NMN, nws tuaj yeem ua haujlwm zoo dua los tiv thaiv kev laus ntawm NMN, txhawb kev noj qab haus huv ntawm tes thiab kev loj hlob.
Cov txiaj ntsig ntawmNMN hmoov
Liposome NMN ntseeg tau tias muaj cov txiaj ntsig zoo hauv qab no: Txhim kho kev nqus tau zoo: Los ntawm encapsulating nws hauv liposomes, solubility thiab stability ntawm NMN tuaj yeem txhim kho, yog li ua kom muaj kev nqus tau zoo rau hauv cov hlwb. Ntxiv bioavailability: Liposomes tuaj yeem pab NMN hla cell membranes zoo dua, txhim kho nws cov bioavailability thiab cia nws ua haujlwm zoo dua. Muab kev tiv thaiv: Liposomes tuaj yeem tiv thaiv NMN los ntawm kev puas tsuaj los ntawm acidic gastric kua txiv thiab lwm yam digestive enzymes, yog li ua kom nws ruaj khov thiab bioavailability nyob rau hauv txoj hnyuv. Feem ntau, liposomal NMN yog cov tshuaj lom neeg uas ua ke nrog liposome technology thiab NMN. Los ntawm kev txhim kho kev ruaj ntseg thiab bioavailability ntawm NMN, nws tuaj yeem ua haujlwm zoo dua los tiv thaiv kev laus ntawm NMN, txhawb kev noj qab haus huv ntawm tes thiab kev loj hlob.
Cov khoom tsom xam | Specifications | Cov txheej txheem |
Cov khoom xyaw nquag kuaj | ||
NMN Kev ntsuam xyuas (HPLC) | ≥99.0% | T/CASME 012-2021 |
NMN Purity (HPLC) | 98.00% -101.00% | T/CASME 012-2021 |
Kev kuaj lub cev | ||
Qhov tshwm sim | Tawm Dawb rau Dawb Fine powder | Pom kev |
Saj & tsw | Spebsaj | Organoleptic |
tus nqi pH | 3.0-4.0 Nws | GB 5009.237 |
Qhov ntom ntom | 0.30-0.65g / ml | GB 5009.2 |
Cov dej noo | ≤0.50 ib% | GB 5009.3 |
Cov ntsiab lus tshauv | ≤0.50% | GB 5009.4 |
Kev kuaj tshuaj | ||
Hnyav Hlau | ≤10.00ppm ua | GB 5009.74 ib |
Pb | ≤0.10ppm ua | GB 5009.12 |
Raws liArsenic> | ≤0.10ppm ua | GB 5009.11 |
Cd | ≤0.20 ibppm ua | GB 5009.15 |
Hg | ≤0.10ppm ua | GB 5009.17 |
Potassium | ≤100ppm ua | GB 5009.91 |
Skev ntxub ntxaug | ≤100ppm ua | GB 5009.91 |
Solvent residual(Ethanol) | ≤1,000ppm ua | GB 5009.262 |
Kev ntsuam xyuas microbiological | ||
Tag nrho cov kab moblCounts | ≤1,000cfu / g | wb 4789.2 |
Yeasts thiab Pwm | ≤25cfu/g | GB 4789.15 |
Coliform | 50MPN / 100g | wb 4789.3 |
E. Coli | Negative hauv 1g | ib 4789.38 |
Salmonella | Negative hauv 10 g | wb 4789.4 |
Skab mob taphylococcus aureus | Negative hauv 1g | GB 4789.10 |
Cov kab mob endotoxin | ≤0.5 EU / mg | Ch.P2020 IV |
* Cov lus qhia:Irradiateddawb, GMO dawb, Additives dawb, Allergen Dawb. |
★ Lub tuam txhab muaj 800,000㎡ cog qoob loo hauv Inner Monglia .
★ Spirulina hmoov thiab extract exported rau ntau tshaj 60 lub teb chaws.
★ Microcystic toxins Dawb, PAHs tsim nyog thiab ETO Dawb.
★ Cov khoom lag luam tsim nyog, tus nqi tsim nyog, kev pabcuam kev ua haujlwm tsis tu ncua.